Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical company with a market capitalization of nearly $120 billion, finds itself at a critical juncture as it navigates a complex landscape of ...
Insurance United Against Dementia (IUAD), the industry-led campaign, has reached its initial £10 million fundraising target, ...
Taiwan-based electronics manufacturer Cincon has launched a new ultra-wide and high-input voltage DC-DC converter series to ...
Over the last three months, we've seen significantly more insider buying, than insider selling, at Bristol-Myers Squibb.
Danny Grubs on MSN23h
Korean man attempts to make fufu💀🤣As Southern California gets some much-needed rain, a new analysis suggests the conditions that led to January's wildfires ...
Dear reader, China’s biotechnology sector has rapidly emerged as one of the fastest-growing industries, with Chinese players ...
Shardul Nautiyal, Mumbai Thursday, January 30, 2025, 08:00 Hrs [IST] ...
High-performance computing systems for AI applications need to be designed, operated and, importantly, maintained with a ...
We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look ...
We recently published a list of Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback